Actively Recruiting

Phase Not Applicable
Age: 18Years - 55Years
All Genders
NCT07066228

Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Long Tubular Bone Defects

Led by The First Affiliated Hospital of Xinxiang Medical College · Updated on 2026-01-02

30

Participants Needed

1

Research Sites

173 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Commercial decalcified bone scaffolds were combined with autologous bone marrow mesenchymal stem cells to form tissue engineered bone in vitro to explore the effect of this tissue engineered bone in the clinical repair of long tubular bone defects in limbs.

CONDITIONS

Official Title

Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Long Tubular Bone Defects

Who Can Participate

Age: 18Years - 55Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 55 years, any gender
  • Defective nonunion with bone loss over 30% of bone cross-section and length of 2-3 cm
  • Solitary bone cysts involving more than 50% of the bone cross-section
Not Eligible

You will not qualify if you...

  • Presence of local tumors, tuberculosis, infections, or other lesions affecting bone healing
  • Systemic diseases impacting bone healing such as osteofibrous dysplasia, osteogenesis imperfecta, bone dystrophic diseases, or metabolic bone disorders
  • Moderate to severe osteoporosis (T-score less than -2.5)
  • Severe systemic conditions including malnutrition, systemic infections, severe heart or lung diseases, coagulation disorders, or organ failure
  • Severe brain trauma
  • Heavy smoking, drug abuse, alcoholism, or other harmful addictions
  • Psychiatric disorders or menopausal symptoms
  • Participation in other clinical trials within the past 4 weeks or currently
  • Pregnancy, breastfeeding, or planned pregnancy within one year after enrollment
  • Psychological conditions impairing treatment compliance
  • Congenital malformations of vital organs or other systems
  • Nonunion caused by malignant tumor resection
  • Refusal to accept tissue-engineered bone repair protocol

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The First Affiliated Hospital of Xinxiang Medical College

Xinxiang, Henan, China, 453000

Actively Recruiting

Loading map...

Research Team

W

Wenjie Ren

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here